Maternal mortality in the United States: research gaps, opportunities, and priorities.

alliance for innovation community engagement epidemiology health disparities levels of maternal care maternal morbidity maternal mortality measurement perinatal collaborative postpartum care pregnancy-related mortality surveillance race and ethnicity social determinants of health surveillance vital statistics

Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
10 2020
Historique:
received: 07 05 2020
revised: 02 07 2020
accepted: 14 07 2020
pubmed: 20 7 2020
medline: 24 11 2020
entrez: 20 7 2020
Statut: ppublish

Résumé

Maternal mortality and severe maternal morbidity are urgent issues in the United States. It is important to establish priority areas to address these public health crises. On April 8, 2019, and May 2 to 3, 2019, the Eunice Kennedy Shriver National Institute of Child Health and Human Development organized and invited experts with varied perspectives to 2 meetings, a community engagement forum and a scientific workshop, to discuss underlying themes involved in the rising incidence of maternal mortality in the United States. Experts from diverse disciplines reviewed current data, ongoing activities, and identified research gaps focused on data measurement and reporting, obstetrical and health system factors, social determinants and disparities, and the community perspective and engagement. Key scientific opportunities to reduce maternal mortality and severe maternal morbidity include improved data quality and measurement, understanding the populations affected as well as the numerous etiologies, clinical research to confirm preventive and interventional strategies, and engagement of community participation in research that will lead to the reduction of maternal mortality in the United States. This article provides a summary of the workshop presentations and discussions.

Identifiants

pubmed: 32682858
pii: S0002-9378(20)30742-0
doi: 10.1016/j.ajog.2020.07.021
pmc: PMC7564012
mid: NIHMS1635237
pii:
doi:

Types de publication

Congress Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-492.e6

Subventions

Organisme : Intramural NIH HHS
ID : Z01 HD008794
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HD999999
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published by Elsevier Inc.

Auteurs

Juanita J Chinn (JJ)

Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD. Electronic address: Juanita.Chinn@nih.gov.

Esther Eisenberg (E)

Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Shavon Artis Dickerson (S)

Office of Health Equity, Office of the Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Rosalind B King (RB)

Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Nahida Chakhtoura (N)

Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Issel Anne L Lim (IAL)

Office of Science Policy, Reporting, and Program Analysis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Katherine L Grantz (KL)

Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Charisee Lamar (C)

Office of Health Equity, Office of the Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Diana W Bianchi (DW)

Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH